The transaction supports Embecta’s plan to diversify by supplying drug delivery solutions to pharmaceutical partners.

Pirouette aims to use their patented technology to revolutionize the $600B injectable medicine market, making life-saving injections as easy as pushing a button PORTSMOUTH, N.H.–(BUSINESS WIRE)–May 7, ...

Embecta has signed a definitive agreement to acquire UK-based Owen Mumford Holdings for up to £150m ($172.6m), to enhance its global presence in drug delivery technologies. The agreement includes an ...

Richmond, VA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injectors, today announced the appointment of Ram Halthore as Vice President, ...

Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice guidance, AUVI-Q ® (epinephrine injection), ...

Embecta closed its acquisition of Owen Mumford Holdings on Friday, shifting its focus from diabetes products to broader ...

DETROIT & BOSTON--(BUSINESS WIRE)--Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated ...

(RTTNews) - Ypsomed Holding AG (YPHDF) announced Monday that its digital connectivity add-on, SmartPilot, has received 510(k) clearance from the U.S. Food and Drug Administration or FDA. SmartPilot ...

PORTSMOUTH, N.H.--(BUSINESS WIRE)--Pirouette, with their innovative auto-injector platform, announced they have surpassed $5M raised in their community investment round on Wefunder, prompting them to ...